CB
Cloverleaf Bio, Inc.
SEC filingBiotechnology · New Haven, CT
Amount raised$14.8Msold at filing
Total offering$29.6M$14.8M still open
Investors in the raise12count reported to the SEC
FiledSep 9, 2026first sale Aug 24, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christina VorvisDirector
Dima KuzminDirector
Cole LewisExecutive Officer
Matthias SamwerDirector
Austin DraycottExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.